|
Link to Bioasis PR re: quarterly financial statements and MD&A for the period ended Nov. 30, 2017
|
2
|
BIOASIS TECHNOLOGIES INC
|
Jan 30, 2018 11:56AM
|
|
Bioasis to Present at the 2018 BIO CEO & Investor Conference
|
2
|
BIOASIS TECHNOLOGIES INC
|
Feb 06, 2018 01:47PM
|
|
Re: Delivery peptide conjugates of Trastuzumab
|
1
|
BIOASIS TECHNOLOGIES INC
|
Mar 21, 2018 04:52AM
|
|
Dr. Deborah Rathjen, CEO & Managing Director of Bionomics Appointed Chair of the Bioasis Board of Directors
|
1
|
BIOASIS TECHNOLOGIES INC
|
Mar 21, 2018 08:45AM
|
|
Re: Dr. Deborah Rathjen, CEO & Managing Director of Bionomics Appointed Chair of the Bioasis Board of Directors
|
1
|
BIOASIS TECHNOLOGIES INC
|
Mar 21, 2018 09:55AM
|
|
Caroline Hill, Ph.D. Appointed SVP, Head of R&D Operations at Bioasis
|
1
|
BIOASIS TECHNOLOGIES INC
|
Mar 26, 2018 08:10AM
|
|
Dr. Mark Day Interview for WSHU, All Things Considered
|
3
|
BIOASIS TECHNOLOGIES INC
|
Apr 11, 2018 04:54PM
|
|
Bioasis & WuXi Biologics Announce Strategic Collaboration to Manufacture xB3-001
|
1
|
BIOASIS TECHNOLOGIES INC
|
May 21, 2018 09:32AM
|
|
Bioasis Announces Publication of Independent Research by MedImmune Validating xB3 Platform Technology
|
2
|
BIOASIS TECHNOLOGIES INC
|
May 30, 2018 08:32AM
|
|
Bioasis Announces Filing of Its Fourth Quarter and Fiscal Year-End Financial Statements and MD&A
|
4
|
BIOASIS TECHNOLOGIES INC
|
Jun 26, 2018 08:29PM
|
|
Syntimmune Picks Up Vertex SVP Saltarelli for CMO
|
3
|
BIOASIS TECHNOLOGIES INC
|
Jul 09, 2018 05:13PM
|
|
Bioasis & BioAgilytix Announce Strategic Partnership to Advance xB3-001
|
3
|
BIOASIS TECHNOLOGIES INC
|
Jul 11, 2018 08:22AM
|
|
Dr. Jeffrey Cummings Receives Two Career Achievement Awards & Takes a Look Back... And Forward
|
2
|
BIOASIS TECHNOLOGIES INC
|
Aug 24, 2018 12:27PM
|
|
First xB3 platform technology licensing agreement with Prothena; USD$1M upfront+potential up to USD$33M in payments
|
4
|
BIOASIS TECHNOLOGIES INC
|
Oct 29, 2018 08:01AM
|
|
First xB3 platform technology licensing agreement with Prothena; USD$1M upfront+potential up to USD$33M in payments
|
4
|
BIOASIS TECHNOLOGIES INC
|
Oct 29, 2018 08:10AM
|
|
Bioasis Announces Filing of Its Quarterly Financial Statements and MD&A for the Period Ending August 31, 2018
|
2
|
BIOASIS TECHNOLOGIES INC
|
Oct 30, 2018 04:31PM
|
|
Bioasis Announces Positive Results from NHP study w/ xB³-001
|
2
|
BIOASIS TECHNOLOGIES INC
|
Nov 20, 2018 09:18PM
|
|
Bioasis Announces Voting Results for 2018 Annual and Special Meeting
|
1
|
BIOASIS TECHNOLOGIES INC
|
Nov 26, 2018 04:49PM
|
|
Bioasis nominated for the Buzz of BIO at the 2019 CEO & Investor Conference
|
6
|
BIOASIS TECHNOLOGIES INC
|
Dec 04, 2018 09:07AM
|
|
Dr. Deborah Rathjen Appointed Executive Chair of the Bioasis Board of Directors
|
5
|
BIOASIS TECHNOLOGIES INC
|
Dec 10, 2018 08:37AM
|
